Logo image of SATS

ECHOSTAR CORP-A (SATS) Stock Fundamental Analysis

NASDAQ:SATS - Nasdaq - US2787681061 - Common Stock - Currency: USD

29.57  -0.6 (-1.99%)

After market: 29.57 0 (0%)

Fundamental Rating

1

SATS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 93 industry peers in the Media industry. SATS may be in some trouble as it scores bad on both profitability and health. SATS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SATS has reported negative net income.
SATS had a positive operating cash flow in the past year.
In multiple years SATS reported negative net income over the last 5 years.
SATS had a positive operating cash flow in each of the past 5 years.
SATS Yearly Net Income VS EBIT VS OCF VS FCFSATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B

1.2 Ratios

SATS has a Return On Assets of -3.82%. This is comparable to the rest of the industry: SATS outperforms 41.38% of its industry peers.
With a Return On Equity value of -11.32%, SATS perfoms like the industry average, outperforming 40.23% of the companies in the same industry.
The Return On Invested Capital of SATS (0.21%) is worse than 71.26% of its industry peers.
SATS had an Average Return On Invested Capital over the past 3 years of 1.94%. This is significantly below the industry average of 7.01%.
Industry RankSector Rank
ROA -3.82%
ROE -11.32%
ROIC 0.21%
ROA(3y)0.36%
ROA(5y)-0.07%
ROE(3y)-0.44%
ROE(5y)-0.84%
ROIC(3y)1.94%
ROIC(5y)1.61%
SATS Yearly ROA, ROE, ROICSATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5

1.3 Margins

SATS has a Operating Margin of 0.52%. This is in the lower half of the industry: SATS underperforms 70.11% of its industry peers.
SATS's Operating Margin has declined in the last couple of years.
SATS has a Gross Margin of 26.87%. This is in the lower half of the industry: SATS underperforms 73.56% of its industry peers.
In the last couple of years the Gross Margin of SATS has declined.
Industry RankSector Rank
OM 0.52%
PM (TTM) N/A
GM 26.87%
OM growth 3Y-22.28%
OM growth 5Y-13.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.06%
GM growth 5Y-12.47%
SATS Yearly Profit, Operating, Gross MarginsSATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SATS is destroying value.
Compared to 1 year ago, SATS has more shares outstanding
Compared to 5 years ago, SATS has more shares outstanding
SATS has a worse debt/assets ratio than last year.
SATS Yearly Shares OutstandingSATS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
SATS Yearly Total Debt VS Total AssetsSATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B 50B

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that SATS is in the distress zone and has some risk of bankruptcy.
SATS has a Altman-Z score (0.84) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.11 is on the high side and indicates that SATS has dependencies on debt financing.
SATS has a worse Debt to Equity ratio (1.11) than 60.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACC0.02
WACC9.84%
SATS Yearly LT Debt VS Equity VS FCFSATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

SATS has a Current Ratio of 0.67. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.67, SATS is doing worse than 86.21% of the companies in the same industry.
A Quick Ratio of 0.61 indicates that SATS may have some problems paying its short term obligations.
With a Quick ratio value of 0.61, SATS is not doing good in the industry: 88.51% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.61
SATS Yearly Current Assets VS Current LiabilitesSATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

3

3. Growth

3.1 Past

SATS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -280.85%.
The Revenue has grown by 1426.74% in the past year. This is a very strong growth!
SATS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.38% yearly.
EPS 1Y (TTM)-280.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
Revenue 1Y (TTM)1426.74%
Revenue growth 3Y108.11%
Revenue growth 5Y57.38%
Sales Q2Q%841.96%

3.2 Future

SATS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -150.76% yearly.
Based on estimates for the next years, SATS will show a decrease in Revenue. The Revenue will decrease by -4.79% on average per year.
EPS Next Y-3691.14%
EPS Next 2Y-661.92%
EPS Next 3Y-399.68%
EPS Next 5Y-150.76%
Revenue Next Year-0.78%
Revenue Next 2Y-1.73%
Revenue Next 3Y-1.33%
Revenue Next 5Y-4.79%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SATS Yearly Revenue VS EstimatesSATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
SATS Yearly EPS VS EstimatesSATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SATS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SATS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SATS Price Earnings VS Forward Price EarningsSATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

SATS's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.88
SATS Per share dataSATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

SATS's earnings are expected to decrease with -399.69% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-661.92%
EPS Next 3Y-399.68%

More info and screens

0

5. Dividend

5.1 Amount

SATS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECHOSTAR CORP-A

NASDAQ:SATS (2/21/2025, 8:00:01 PM)

After market: 29.57 0 (0%)

29.57

-0.6 (-1.99%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)05-06 2025-05-06/bmo
Inst Owners94.65%
Inst Owner Change19.66%
Ins Owners13.29%
Ins Owner Change0.69%
Market Cap8.04B
Analysts73.85
Price Target30.09 (1.76%)
Short Float %13.89%
Short Ratio10.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-113.27%
Min EPS beat(2)-197.05%
Max EPS beat(2)-29.49%
EPS beat(4)0
Avg EPS beat(4)-265.47%
Min EPS beat(4)-752.94%
Max EPS beat(4)-29.49%
EPS beat(8)4
Avg EPS beat(8)-83.89%
EPS beat(12)5
Avg EPS beat(12)-59.19%
EPS beat(16)9
Avg EPS beat(16)126.47%
Revenue beat(2)0
Avg Revenue beat(2)-2.55%
Min Revenue beat(2)-2.69%
Max Revenue beat(2)-2.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.85%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)4.78%
Revenue beat(8)2
Avg Revenue beat(8)-2.87%
Revenue beat(12)4
Avg Revenue beat(12)-1.96%
Revenue beat(16)8
Avg Revenue beat(16)-1.2%
PT rev (1m)23.78%
PT rev (3m)31.11%
EPS NQ rev (1m)7.85%
EPS NQ rev (3m)-14%
EPS NY rev (1m)-5.66%
EPS NY rev (3m)-11.82%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF 2.41
P/B 0.41
P/tB 0.42
EV/EBITDA 10.88
EPS(TTM)-2.55
EYN/A
EPS(NY)-2.9
Fwd EYN/A
FCF(TTM)-2.71
FCFYN/A
OCF(TTM)12.28
OCFY41.54%
SpS101.41
BVpS71.52
TBVpS71.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.82%
ROE -11.32%
ROCE 0.29%
ROIC 0.21%
ROICexc 0.21%
ROICexgc 0.21%
OM 0.52%
PM (TTM) N/A
GM 26.87%
FCFM N/A
ROA(3y)0.36%
ROA(5y)-0.07%
ROE(3y)-0.44%
ROE(5y)-0.84%
ROIC(3y)1.94%
ROIC(5y)1.61%
ROICexc(3y)2.63%
ROICexc(5y)2.35%
ROICexgc(3y)3.09%
ROICexgc(5y)2.8%
ROCE(3y)2.72%
ROCE(5y)2.26%
ROICexcg growth 3Y-39.21%
ROICexcg growth 5Y-18.25%
ROICexc growth 3Y-34.39%
ROICexc growth 5Y-15.93%
OM growth 3Y-22.28%
OM growth 5Y-13.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.06%
GM growth 5Y-12.47%
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Debt/EBITDA 7.43
Cap/Depr 147.83%
Cap/Sales 14.78%
Interest Coverage 0.06
Cash Conversion 115.1%
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.61
Altman-Z 0.84
F-Score3
WACC9.84%
ROIC/WACC0.02
Cap/Depr(3y)122.18%
Cap/Depr(5y)106.75%
Cap/Sales(3y)19.82%
Cap/Sales(5y)21.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-280.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
EPS Next Y-3691.14%
EPS Next 2Y-661.92%
EPS Next 3Y-399.68%
EPS Next 5Y-150.76%
Revenue 1Y (TTM)1426.74%
Revenue growth 3Y108.11%
Revenue growth 5Y57.38%
Sales Q2Q%841.96%
Revenue Next Year-0.78%
Revenue Next 2Y-1.73%
Revenue Next 3Y-1.33%
Revenue Next 5Y-4.79%
EBIT growth 1Y-3.64%
EBIT growth 3Y61.74%
EBIT growth 5Y36.68%
EBIT Next Year231.38%
EBIT Next 3Y42.41%
EBIT Next 5Y17.09%
FCF growth 1Y-494.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y509.71%
OCF growth 3Y65.73%
OCF growth 5Y27.06%